Epicardial adipose excision slows the progression of porcine coronary atherosclerosis
- Mikaela L McKenney†1,
- Kyle A Schultz†1,
- Jack H Boyd2,
- James P Byrd1,
- Mouhamad Alloosh1,
- Shawn D Teague3,
- Arturo A Arce-Esquivel4,
- John N Fain5,
- M Harold Laughlin4,
- Harold S Sacks6, 7 and
- Michael Sturek1Email author
© McKenney et al.; licensee BioMed Central Ltd. 2014
Received: 1 August 2013
Accepted: 25 November 2013
Published: 3 January 2014
In humans there is a positive association between epicardial adipose tissue (EAT) volume and coronary atherosclerosis (CAD) burden. We tested the hypothesis that EAT contributes locally to CAD in a pig model.
Ossabaw miniature swine (n = 9) were fed an atherogenic diet for 6 months to produce CAD. A 15 mm length by 3–5 mm width coronary EAT (cEAT) resection was performed over the middle segment of the left anterior descending artery (LAD) 15 mm distal to the left main bifurcation. Pigs recovered for 3 months on atherogenic diet. Intravascular ultrasound (IVUS) was performed in the LAD to quantify atheroma immediately after adipectomy and was repeated after recovery before sacrifice. Coronary wall biopsies were stained immunohistochemically for atherosclerosis markers and cytokines and cEAT was assayed for atherosclerosis-related genes by RT-PCR. Total EAT volume was measured by non-contrast CT before each IVUS.
Circumferential plaque length increased (p < 0.05) in the proximal and distal LAD segments from baseline until sacrifice whereas plaque length in the middle LAD segment underneath the adipectomy site did not increase. T-cadherin, scavenger receptor A and adiponectin were reduced in the intramural middle LAD. Relative to control pigs without CAD, 11β-hydroxysteroid dehydrogenase (11βHSD-1), CCL19, CCL21, prostaglandin D2 synthase, gp91phox [NADPH oxidase], VEGF, VEGFGR1, and angiotensinogen mRNAs were up-regulated in cEAT. EAT volume increased over 3 months.
In pigs used as their own controls, resection of cEAT decreased the progression of CAD, suggesting that cEAT may exacerbate coronary atherosclerosis.
KeywordsAtherosclerosis Computed tomography Surgery Intravascular ultrasound
In most recent reviews of human cross-sectional studies [1–3], the amount of epicardial adipose tissue (EAT), measured either as thickness by echocardiography over the right ventricle or as total volume by computed tomography (CT) scans, correlated directly with coronary artery disease (CAD) burden. Additionally, in prospective case-cohort  and in case–control  studies, EAT volume predicted future CAD events and myocardial ischemia. However, one report did not show that EAT volume added incremental predictive value over established CAD risk factors .
After regression analysis, EAT volume expansion in CAD occurs independently of associated increases in visceral abdominal and total body fat mass as well as changes in other CAD risk factors [2, 3]. This epidemiological evidence together with pathophysiological data showing increased chronic inflammatory cell infiltrates  and up-regulation of pro-inflammatory, redox, macrophage marker, and angiogenic gene expression specifically in EAT sampled from humans undergoing coronary artery bypass for severe CAD  is the basis for the hypothesis that EAT might contribute locally and detrimentally to coronary atherogenesis. However, to our knowledge, there is no direct experimental evidence that EAT plays a role in coronary atherogenesis.
Our laboratory has characterized Ossabaw miniature swine as a model of CAD. The “thrifty genotype” of Ossabaw swine has enabled survival in the feast and famine ecology, i.e. extreme variations in food availability, of Ossabaw Island . In the sedentary environment of captivity, our group induced CAD in this breed of pigs by feeding them a hypercaloric, atherogenic diet [9–12]. This animal’s coronary arterial supply more closely resembles that of humans compared to rodent research models. Additionally, rodent EAT is unpredictable in amount and not easily discerned, whereas the pig’s EAT is clearly demarcated macroscopically [9, 11], can be imaged radiologically , and potentially might be amenable to surgical removal . We tested the hypothesis that surgical excision of EAT in direct contact with the coronary artery (cEAT) of pigs would attenuate underlying plaque progression in vivo.
Animal model and protocol
We produced CAD in 9 castrated male Ossabaw miniature swine by feeding them 1000 g, once a day, of a high fat/cholesterol/fructose, atherogenic diet for 6 months starting at 6 months of age. The diet provided 16.3% kcal from protein, 40.8% kcal from complex carbohydrates, 19% kcal from fructose, and 42.9% kcal from fat. Fat calories derived from a mixture of lard, hydrogenated soybean oil, and hydrogenated coconut oil. It was supplemented with 2.0% cholesterol and 0.7% sodium cholate by weight (KT324, Purina Test Diet, Richmond, IN). Age- and gender-matched lean control swine were fed 750 g of regular chow (5 L80, Purina Test Diet, Richmond, IN) containing 18% kcal from protein, 71% kcal from complex carbohydrates, and 11% kcal from fat once a day. All animals had free access to drinking water. After 6 months on the diet, CT was performed to quantify EAT surrounding the heart. Surgical excision of cEAT covering the middle segment of the left anterior descending (LAD) artery, which we termed selective coronary adipectomy, was then conducted via a thoracotomy, as described below, followed immediately by intravascular ultrasound (IVUS) quantification of CAD. Following the procedure, the same baseline diet was continued during a 3-month recovery period at the end of which identical CT followed by IVUS were performed prior to sacrifice and tissue collection. Control pigs did not undergo IVUS or adipectomy because they have been shown previously to develop minimal or no CAD over the time course of this experiment . In both adipectomy and control pigs at sacrifice, cEAT for mRNA analysis was resected from the adventitial surface of the LAD just proximal to the middle LAD adipectomy site, and as a comparator, paracardial fat was sampled from the mediastinal surface of the pericardium towards the apex of the heart. Samples were stored at −80°C. Biopsies of proximal, middle and distal LAD were taken and preserved for immunohistochemistry. All protocols involving animals were approved by an Institutional Animal Care and Use Committee and complied fully with recommendations in the Guide for the Care and Use of Laboratory Animals and the American Veterinary Medical Association Panel on Euthanasia .
Following an overnight fast, swine received a 2.2 mg/kg of xylazine (Webster Veterinary, Devens, MA) and 5.5 mg/kg of telazol (Fort Dodge Animal Health, Fort Dodge, IA) intramuscular injection to induce anesthesia. Swine were intubated and anesthesia was maintained with 2-4% isoflurane in 100% O2 as a carrier gas. The isoflurane level was adjusted to maintain anesthesia with stable hemodynamics. Heart rate, aortic blood pressure, respiratory rate, and electrocardiographic data were continuously monitored throughout the procedure. A 7 F introducer sheath was inserted into the right femoral artery and heparin (200 U/kg) was administered under sterile conditions. A 7 F guiding catheter (Amplatz L, sizes 0.75-2.0; Cordis, Bridgewater, NJ) was advanced to engage the left main coronary ostium. A 3.2 F, 30 MHz IVUS catheter (Boston Scientific, Natick, MA) was advanced over a 0.014 inch diameter percutaneous transluminal coronary angioplasty guide wire (Boston Scientific, Natick, MA) and positioned in the LAD. Automated IVUS pullbacks were performed at 0.5 mm/sec in the LAD. Throughout the procedure angiography was performed to place the guiding and IVUS catheters in their desired positions. The IVUS catheter, guide catheter, and introducer sheath were removed and the right femoral artery ligated. The incision was closed and the animal was allowed to recover. Cefazolin (1000 mg; WG Critical Care, Lake Forest, IL) was given twice a day for six days following the procedure.
All IVUS pullback images were analyzed off-line (Windows Media Player, Microsoft) at 1 mm intervals. The LAD was divided into 3 segments: proximal (0–15 mm), middle (15–30 mm) and distal (30–45 mm) with 0 mm starting at the bifurcation of the left main into LAD and circumflex. Three IVUS pullback images were captured per vessel segment. Using the Image-Pro Plus software (Media Cybernetics, Rockville, MD), lumen area (LA) was found by tracing the vessel lumen. From LA, lumen circumference (LC) was calculated for each vessel segment by the following formula: LC = 2π [√ (LA/π)]. To derive wall coverage (WC) by plaque, the circumference of each cross-sectional image was divided into 16 equal segments. Percent wall coverage was calculated as (# segments containing atheroma ÷ 16) × 100. From the product of average WC × LC, a circumferential plaque length for each vessel segment was found. As an example, the following results are presented from a proximal coronary artery segment:
LA 21.40 mm2; LC 16.40 mm; WC 29.58%; circumferential plaque length = 4.85 mm. Pullbacks were used for 7 out of 9 animals due to restrictions from vasospasms or lumen diameter. Using a 2-way analysis of variance (ANOVA), average circumferential plaque length per vessel segment was compared pre- and post-adipectomy.
Sections of the LAD were prepared using techniques previously described by us . Samples of LAD were dissected and immersed in neutral-buffered 10% formalin for a minimum of 24 h and then processed to paraffin embedment. The proximal, middle, and distal samples of LAD were obtained consistently from the same location in all pigs. Five-micrometer sections were cut with an automated microtome (Microm, Thermo Fischer Scientific, Bellefonte, PA), floated onto positively charged slides (Thermo Fischer Scientific), and deparaffinized. The slides were then steamed in citrate buffer at pH 6.0 (Dako target retrieval solution S1699; Dako, Carpenteria, CA) for 30 min to achieve antigen retrieval and subsequently cooled for 30 min. Next, the slides were stained manually with sequential Tris buffer or water wash steps performed after each protocol step. Sections were incubated with avidin biotin two step blocking solution (Vector SP-2001; Vector Laboratories, Burlingame, CA) to inhibit background staining and in 3% hydrogen peroxide to inhibit endogenous peroxidase. Nonserum protein block (Dako X909; Dako) was applied to inhibit nonspecific protein binding. Immunostaining was performed using scavenger receptor A (SRA-ES; 1:100 dilution, Transgenic Inc. #KT-022), tryptase (1:600 dilution, Dako #M7052), CD-3 (1:600 dilution, Dako #A0452), monocyte chemoattractant protein-1 (MCP-1; 1:100 dilution, PeproTech #500-P76), resistin (1:800 dilution, Phoenix Pharmaceuticals #H-02840), T-cadherin (1:1000 dilution, Abgent #CDH13, AP14346), adiponectin (1:200, Chemicon #MAB 3604) or tumor necrosis factor-alpha (TNF-alpha; 1:100 dilution, R&D #AF690). All the primary antibodies were diluted using antibody diluent (S0809; Dako) and were incubated with the tissue sections overnight at 4-C. After the appropriate washing was completed, sections were incubated with biotinylated antimouse or rabbit link secondary antibody and then peroxidase-labeled streptavidin (LSAB + kit, peroxidase, K0690; Dako). Diaminobenzidine (K3468; Dako) was applied for 5 min and allowed visualization of primary antibody staining. Sections were counterstained with Mayer hematoxylin for 1 min, dehydrated, and coverslipped. For negative controls, histological sections were prepared as described, but incubation in primary antibody was replaced with Tris buffer.
Immunostaining analysis was performed in the entire vessel wall (i.e. intima to external elastic lamina boundaries) in order to quantify the presence of SRA, tryptase, CD3, MCP-1, resistin, T-cadherin, adiponectin or TNF-alpha. Sections were examined using an Olympus BX61 photomicroscope (Olympus, Melville, NY), and pictures were captured at 20x magnification. Image-Pro Plus (version 188.8.131.524; Media Cybernetics, Inc., Silver Spring, MD) was used to identify and quantify the positive area of staining. Percent staining of the vessel wall was calculated from the data for positive staining and total area. An experienced investigator that was blinded to treatment group’s identities performed the selection of target areas, photography, and image analysis.
Approximately 0.2 to 0.5 g of frozen cEAT and paracardial fat from adipectomy and control animals was homogenized with 5 ml of a monophasic solution of phenol and guanidine isothiocyanate (TRIzol reagent, Invitrogen, Carlsbad, CA).
Ratio of gene expression in fat from obese and lean Ossabaw pigs
Ratio of obese/lean
Inflammatory adipokines or proteins associated with inflammation
Prostaglandin D2 synthase
Oxidative stress/reactive oxygen species regulation
gp91phox [NADPH oxidase]
cytochrome C oxidase
Angiogenesis and endothelial cell function
adenosine receptor 1
Statistical analysis was performed via Microsoft Excel 2010, utilizing ANOVA, regression analysis and post hoc 1- and 2-tailed paired student t-tests to examine significance. All values are given as mean ± SE. A p value <0.05 was considered statistically significant.
Metabolic characteristics of Ossabaw swine
Obese (n = 9)
Lean (n = 9)
Weight at adipectomy (kg)
77 ± 3
Weight at sacrifice (kg)
91 ± 1
54 ± 2
Total cholesterol (mg/dL)
576 ± 40
57 ± 6
Fasting triglycerides (mg/dL)
108 ± 21
32 ± 3
502 ± 36
33 ± 1
53 ± 7
24 ± 2
11 ± 2
1 ± 0.1
Fasting glucose (mg/dL)
80 ± 5
73 ± 6
Plasma glucose peak (mg/dL)
820 ± 35
527 ± 24
Plasma glucose AUC
17138 ± 1004
9274 ± 377
Fasting insulin (μU/ml)
21 ± 6
5 ± 1
Plasma insulin peak (μU/ml)
172 ± 19
33 ± 4
Plasma insulin AUC
4413 ± 432
667 ± 121
Systolic blood pressure (mmHg)
138 ± 2
110 ± 3
Diastolic blood pressure (mmHg)
79 ± 2
67 ± 2
CT quantification of epicardial fat
Table 1 shows the expression in cEAT and paracardial fat of genes linked to atherogenesis, namely those involved in inflammation, reactive oxygen species and redox reactions, angiogenesis and endothelial cell function. The data in each fat depot are expressed as the ratio of experimental to control pig fat depots. In EAT, there were significant and substantial fold increases in mRNA expression of pro-inflammatory 11β-hydroxysteroid dehydrogenase (11βHSD-1), CCL19, CCL21 and PGD2S; anti-inflammatory adiponectin; pro-oxidant gp91phox [NADPH oxidase], angiogenic VEGF and VEGFGR1 and vascoconstrictive angiotensinogen. There were no changes in pro-inflammatory toll-like receptor 4 [TLR4], CCR7, TNFα, IL-1β, IL-6, IL-8, leptin, Unc5b, netrin-1 and NGF; redox genes eNOS, superoxide dismutase [SOD], cyclooxygenase 2 and cytochrome oxidase; and vasoconstrictor endothelin-1 and vasodilator adenosine receptor 1. By contrast, in paracardial fat relative to cEAT, 11βHSD-1 and CCL21 were normal; CCL19, PGD2S, adiponectin pro-oxidant gp91phox [NADPH oxidase] VEGF, VEGFGR1 and angiotensinogen were up-regulated to much lesser degrees; and the remaining genes were similar except for TLR4 and endothelin-1 which were modestly (~2 fold) increased.
We present experimental evidence that, in Ossabaw miniature swine, selective surgical excision of adipose tissue in direct contiguity with one of the epicardial coronary arteries attenuated the progression of atherosclerosis, thus supporting the hypothesis that cEAT could contribute to underlying coronary atherogenesis . The findings are applicable to the early stages of CAD because of the relatively young age of the animals, the short duration of atherogenic diet feeding, and the lack of observed flow-limiting coronary stenosis typical of advanced clinical disease. We acknowledge the substantially high LDL cholesterol levels (>500 m/dL) in the obese group. We have conducted other studies in which the LDL was ~250 mg/dL (e.g. [10, 12]) for a longer duration, which yielded substantial coronary atherosclerosis. We predict a similar result of adipectomy. This very high LDL cholesterol level for a short duration is similar to LDLR−/− humans, who have substantial atherosclerosis. Horton and colleagues refer to this phenomenon as the effect of cumulative LDL cholesterol in g/dL-years .
We showed that in the middle LAD at the adipectomy site, progression of CAD was not significant compared to the significant increases in circumferential plaque in the adjacent, unperturbed proximal and distal segments. Thus, in the middle LAD segment, the increase in mean plaque length was 1.4-fold compared to 1.9- and 2.9-fold in the proximal and distal LAD, respectively. There were higher mean values and greater variability in baseline plaque length in the middle compared to the proximal and distal segments at the time of adipectomy, suggesting that the attenuated progression of atheroma could have been the consequence of higher initial plaque thickness at the inception of the protocol. However, a two-tailed, paired t-test did not indicate that this baseline difference was statistically significant (p = 0.26). The reason for the variability in the middle LAD plaque dimensions is not clear, since prior studies have indicated that mean plaque burden is greatest proximally and decreases distally in the LAD . One possibility is that adipectomy could have perturbed underlying plaque structure or vasomotor responses and interfered with IVUS measurements performed under heparin immediately after adipectomy. However, we have recently shown that cEAT has uniformly adverse effects on coronary artery function , in contrast to protective effect of PVAT in the aorta and other arteries. This explains why we observed no adverse mechanical changes after adipectomy.
We resected fat from one coronary artery for several reasons. Resection of as much fat as possible off the entire myocardium was not technically possible in vivo. cEAT on the LAD was the most accessible site within the operative field of exposure compared to either the circumflex or right coronary arteries, which would lessen both intraoperative trauma, morbidity and mortality, and the risk of post-operative complications. This strategy targeting one rather than two vessels was subsequently vindicated by the low intraoperative mortality (1 of 9 pigs) and no noticed post-operative complications. Finally, the longitudinal time course of the experiment enabled the pigs to act as their own controls. Immunoreactivity for T-cadherin was predominantly localized to the endothelium as previously established , but also to the neo-intima. It is considered to be a marker of active atherosclerosis  and a major receptor for adiponectin in the vasculature . T-cadherin and SRA, the scavenger receptor for LDL-cholesterol on plasma membranes of plaque macrophages and foam cells [24, 25], were reduced in the middle LAD intima-media implying less atherogenesis. Paradoxically, anti-inflammatory immunoreactive adiponectin in the same LAD segment was reduced significantly by 68%, despite a ~7-fold upregulation of adiponectin mRNA expression in overlying cEAT; thus, one might surmise that adiponectin released by epicardial adipocytes might not have been able to penetrate the coronary wall if such a mechanism exists. While a majority of the literature describes a decrease in adiponectin expression in CAD patients, we speculate that the 6.7-fold increase in obese pig cEAT mRNA was a compensatory response and that there must be some block in mRNA translation. We have previously reported that serum adiponectin is decreased in obese versus lean Ossabaw swine . On the other hand, there were no changes in vessel wall CD3 (a T lymphocyte cell marker), tryptase (a basophil marker), TNFα, MCP-1, and resistin.
The mechanisms whereby selective adipectomy might have attenuated the progression of CAD remain to be established, but hypothetically include (i) the removal of factors generated by cEAT that could contribute to atherogenesis by direct diffusion through the porous adventitia into the coronary intima-media , such as reactive oxygen species (ROS) and pro-inflammatory cytokines and/or (ii) the disruption of vasa vasorum in the adventitia and in the closely adjacent cEAT , which might interfere with vasocrine signaling of atherogenic adipokines  and restrict mononuclear cell access into the intima-media. The evidence for these suppositions includes the fact that relative to control cEAT, there was significant up-regulation in atherosclerotic cEAT of pro-inflammatory 11βHSD-1, CCL19, CCL21 and PGD2S; gp91phox [NADPH oxidase], a major source of vascular ROS; VEGF and VEGFGR1, which partake in vasa vasorum neogenesis and angiotensinogen, which promotes endothelial dysfunction and vasoconstriction. Similar to our current findings in pigs, we reported 3-fold up-regulation of 11βHSD-1 gene expression in human EAT adjacent to severe CAD over controls without CAD . Pharmacological inhibition of 11βHSD-1 prevented aortic plaque progression in a murine model of atherosclerosis, suggesting that 11βHSD-1 may play a role in atherogenesis . Lymphoid chemokines CCL19 and CCL21 are crucial for the recruitment of circulating naive T cells into lymph nodes. Increased levels of CCL19 and CCL21 have been reported within the atherosclerotic lesions of ApoE−/− mice, in human atherosclerotic carotid plaques, and in plasma of CAD patients . In mice, PGD2S deficiency induces obesity and facilitates aortic atherosclerosis , suggesting it is normally protective and anti-atherogenic in this species. The role of PGD2S in porcine atherosclerosis has not been reported, but -regulation of PGD2S in EAT in our study was associated with amelioration of atherosclerosis, suggesting the possibility that this pro-inflammatory prostanoid might otherwise be harmful either alone or in conjunction with other adipokines. No changes were observed in cEAT in the expression of TLR4 and acute phase cytokines TNFα, IL-1β, IL-6, IL-8 as well as the anti-oxidant genes eNOS and SOD. Finally, the enhanced expression of a selected array of pro-atherosclerotic genes in cEAT over paracardial fat attests to the relative specificity of the genomic response of cEAT associated with CAD that has been similarly documented in humans with CAD .
Epicardial fat volume determined by sequential CT scans significantly increased over 3 months of hypercaloric feeding under the same conditions previously shown to result in major expansion of visceral retroperitoneal and intraperitoneal as well as subcutaneous abdominal fat depots in the same animal model . Although our experimental design using pigs as their own controls in a longitudinal study has its strengths, there are also limitations in the lack of sham-adipectomies in age- and gender-matched pigs fed hypercaloric atherogenic diet. Future studies should employ sham-operated animals; randomization of experimental and control pigs; blinding of both the ultrasonographer and two independent IVUS data analysts to the pig group designation; reversing heparin anti-coagulation during IVUS with protamine sulphate so that IVUS can be done before surgery; CT scanning using radio-contrast dye to delineate the coronaries and to quantitate cEAT area around coronary plaques per se rather than EAT covering the entire myocardium; and immunohistochemical and mRNA analysis of cEAT and the coronary wall for expression of genes and proteins known to be important mediators of or participants in atherogenesis. To make these studies more translatable to clinical treatment, more clinical outcomes studies in the swine model would be helpful, for example, monitoring hard clinical endpoints such as MI, fatal events, etc. over a longer duration.
Our translational research project was done using experimental conditions prohibited in man by obvious ethical constraints and, with the provisos noted above, supports the human epidemiological evidence for a direct relationship between EAT and CAD. At this juncture and until more rigorous evidence is available one way or the other, it is premature to advocate an adipectomy as surgical treatment to attenuate the progression of CAD. Rather, it would be more appropriate from a clinical point of view if non-invasive methods were devised to shrink epicardial fat volume to serve the same beneficial purpose. In this regard, weight loss by caloric restriction and/or exercise in obese human subjects is associated with shrinkage of EAT volume by 9-32% of baseline in different reports [13, 31], but it is not known whether this is accompanied by decreases in chronic inflammation in EAT or reduction in CAD burden .
The results of our pilot study are consistent with the hypothesis that selective coronary artery adipectomy attenuates the progression of early atherosclerosis, setting the stage for performing definitive future studies using sham operation controls. These studies will determine whether coronary adipectomy attenuates stable atherosclerotic plaques typically found in clinically advanced disease.
Coronary artery disease
coronary epicardial adipose tissue
Epicardial adipose tissue
High density lipoprotein
Left anterior descending coronary artery
Low density lipoprotein
myocardial epicardial adipose tissue
Region of interest
Quantitative computed tomography angiography.
The authors would like to acknowledge Doug Bowles, PhD (University of Missouri) for his consultation on histology and review of the manuscript.
NIH HL062552 (MS, MLM, KAS, JPB, MA), P01 HL052490 (MHL), Cardiometabolic Disease Research Foundation, Los Angeles, CA (HS, MS), and NIH/NCATS CTSI TL1 TR000162 (MLM).
- Ouwens DM, Sell H, Greulich S, Eckel J: The role of epicardial and perivascular adipose tissue in the pathophysiology of cardiovascular disease. J Cell Mol Med. 2010, 14: 2223-2234. 10.1111/j.1582-4934.2010.01141.x.View ArticlePubMedPubMed CentralGoogle Scholar
- Verhagen SN, Visseren FLJ: Perivascular adipose tissue as a cause of atherosclerosis. Atherosclerosis. 2011, 214: 3-10. 10.1016/j.atherosclerosis.2010.05.034.View ArticlePubMedGoogle Scholar
- Iozzo P: Myocardial, perivascular, and epicardial fat. Diabetes Care. 2011, 34: S371-S379. 10.2337/dc11-s250.View ArticlePubMedPubMed CentralGoogle Scholar
- Ding J, Hsu FC, Harris TB, Liu Y, Kritchevsky SB, Szklo M, Ouyang P, Espeland MA, Lohman KK, Criqui MH, Allison M, Bluemke DA, Carr JJ: The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr. 2009, 90: 499-504. 10.3945/ajcn.2008.27358.View ArticlePubMedPubMed CentralGoogle Scholar
- Tamarappoo B, Dey D, Shmilovich H, Nakazato R, Gransar H, Cheng VY, Friedman JD, Hayes SW, Thomson LEJ, Slomka PJ, Rozanski A, Berman DS: Increased pericardial fat volume measured from noncontrast CT predicts myocardial ischemia by SPECT. J Am Coll Cardiol Img. 2010, 3: 1104-1112. 10.1016/j.jcmg.2010.07.014.View ArticleGoogle Scholar
- Cheng VY, Dey D, Tamarappoo B, Nakazato R, Gransar H, Miranda-Peats R, Ramesh A, Wong ND, Shaw LJ, Slomka PJ, Berman DS: Pericardial fat burden on ECG-gated noncontrast CT in asymptomatic patients who subsequently experience adverse cardiovascular events. J Am Coll Cardiol Img. 2010, 3: 352-360. 10.1016/j.jcmg.2009.12.013.View ArticleGoogle Scholar
- Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, Sarov-Blat L, O'Brien S, Keiper EA, Johnson AG, Martin J, Goldstein BJ, Shi Y: Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003, 108: 2460-2466. 10.1161/01.CIR.0000099542.57313.C5.View ArticlePubMedGoogle Scholar
- Sacks HS, Fain JN, Cheema P, Bahouth SW, Garrett E, Wolf RY, Wolford D, Samaha J: Depot-specific overexpression of proinflammatory, redox, endothelial cell, and angiogenic genes in epicardial fat adjacent to severe stable coronary atherosclerosis. Metab Syndr Relat Disord. 2011, 9 (6): 433-439. 10.1089/met.2011.0024.View ArticlePubMedGoogle Scholar
- Sturek M, Alloosh M, Wenzel J, Byrd JP, Edwards JM, Lloyd PG, Tune JD, March KL, Miller MA, Mokelke EA, Brisbin IL: Ossabaw Island miniature swine: cardiometabolic syndrome assessment. Swine in the Laboratory: Surgery, Anesthesia, Imaging, and Experimental Techniques. Edited by: Swindle MM. 2007, Boca Raton: CRC Press, 397-402. 2View ArticleGoogle Scholar
- Edwards JM, Neeb ZP, Alloosh MA, Long X, Bratz IN, Peller CR, Byrd JP, Kumar S, Obukhov AG, Sturek M: Exercise training decreases store-operated Ca2+ entry associated with metabolic syndrome and coronary atherosclerosis. Cardiovasc Res. 2010, 85: 631-640. 10.1093/cvr/cvp308.View ArticlePubMedGoogle Scholar
- Payne GA, Borbouse L, Kumar S, Neeb Z, Alloosh M, Sturek M, Tune JD: Epicardial perivascular adipose-derived leptin exacerbates coronary endothelial dysfunction in metabolic syndrome via a protein kinase C-β pathway. Arterioscler Thromb Vasc Biol. 2010, 30: 1711-1717. 10.1161/ATVBAHA.110.210070.View ArticlePubMedPubMed CentralGoogle Scholar
- Neeb ZP, Edwards JM, Alloosh MA, Long X, Mokelke EA, Sturek M: Metabolic syndrome and coronary artery disease in Ossabaw compared with Yucatan swine. Comp Med. 2010, 60: 300-315.PubMedPubMed CentralGoogle Scholar
- Sacks HS, Fain JN: Human epicardial fat: what is new and what is missing?. Clin Exp Pharmacol Physiol. 2011, 38: 879-887. 10.1111/j.1440-1681.2011.05601.x.View ArticlePubMedGoogle Scholar
- Institute for Laboratory Animal Research: Guide for the care and use of laboratory animals. 2010, Washington, D.C.: National Academy Press, 8Google Scholar
- AVMA Panel on Euthanasia: American veterinary medical association: 2000 report of the AVMA panel on euthanasia. JAVMA. 2001, 218: 669-696.View ArticleGoogle Scholar
- Arce-Esquivel AA, Kreutzer KV, Rush JW, Turk JR, Laughlin MH: Exercise does not attenuate early CAD progression in a pig model. Med Sci Sports Exerc. 2012, 44: 27-38. 10.1249/MSS.0b013e318228879b.View ArticlePubMedPubMed CentralGoogle Scholar
- Bustin SA: Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol. 2000, 25: 169-193. 10.1677/jme.0.0250169.View ArticlePubMedGoogle Scholar
- Greif M, Becker A, von Ziegler F, Lebherz C, Lehrke M, Broedl UC, Tittus J, Parhofer K, Becker C, Reiser M, Knez A, Leber AW: Pericardial adipose tissue determined by dual source CT is a risk factor for coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 2009, 29: 781-786. 10.1161/ATVBAHA.108.180653.View ArticlePubMedGoogle Scholar
- Sacks HS, Fain JN: Human epicardial adipose tissue: a review. Am Heart J. 2007, 153: 907-917. 10.1016/j.ahj.2007.03.019.View ArticlePubMedGoogle Scholar
- Horton JD, Cohen JC, Hobbs HH: PCSK9: a convertase that coordinates LDL catabolism. J Lipid Res. 2009, 50: S172-S177.View ArticlePubMedPubMed CentralGoogle Scholar
- Owen MK, Witzmann FA, McKenney ML, Lai X, Berwick ZC, Moberly SP, Alloosh M, Sturek M, Tune JD: Perivascular adipose tissue potentiates contraction of coronary vascular smooth muscle: influence of obesity. Circulation. 2013, 128: 9-18. 10.1161/CIRCULATIONAHA.112.001238.View ArticlePubMedPubMed CentralGoogle Scholar
- Philippova M, Suter Y, Toggweiler S, Schoenenberger AW, Joshi MB, Kyriakakis E, Erne P, Resink TJ: T-cadherin is present on endothelial microparticles and is elevated in plasma in early atherosclerosis. Eur Heart J. 2011, 32: 760-771. 10.1093/eurheartj/ehq206.View ArticlePubMedGoogle Scholar
- Takeuchi T, Adachi Y, Ohtsuki Y, Furihata M: Adiponectin receptors, with special focus on the role of the third receptor, T-cadherin, in vascular disease. Med Mol Morphol. 2007, 40: 115-120. 10.1007/s00795-007-0364-9.View ArticlePubMedGoogle Scholar
- Kodama T, Freeman M, Rohrer L, Zabrecky J, Matsudaira P, Krieger M: Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils. Nature. 1990, 343: 531-535. 10.1038/343531a0.View ArticlePubMedGoogle Scholar
- Matsumoto A, Naito M, Itakura H, Ikemoto S, Asaoka H, Hayakawa I, Kanamori H, Aburatani H, Takaku F, Suzuki H: Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions. Proc Natl Acad Sci USA. 1990, 87: 9133-9137. 10.1073/pnas.87.23.9133.View ArticlePubMedPubMed CentralGoogle Scholar
- Lee L, Alloosh M, Saxena R, Van Alstine W, Watkins BA, Klaunig JE, Sturek M, Chalasani N: Nutritional model of steatohepatitis and metabolic syndrome in the Ossabaw miniature swine. Hepatology. 2009, 50: 56-67. 10.1002/hep.22904.View ArticlePubMedPubMed CentralGoogle Scholar
- Zhu XY, Bentley MD, Chade AR, Ritman EL, Lerman A, Lerman LO: Early changes in coronary artery wall structure detected by microcomputed tomography in experimental hypercholesterolemia. Am J Physiol Heart Circ Physiol. 2007, 293: H1997-H2003. 10.1152/ajpheart.00362.2007.View ArticlePubMedGoogle Scholar
- Damas JK, Smith C, Oie E, Fevang B, Halvorsen B, Waehre T, Boullier A, Breland U, Yndestad A, Ovchinnikova O, Robertson AK, Sandberg WJ, Kjekshus J, Tasken K, Froland SS, Gullestad L, Hansson GK, Quehenberger O, Aukrust P: Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization. Arterioscler Thromb Vasc Biol. 2007, 27: 614-620. 10.1161/01.ATV.0000255581.38523.7c.View ArticlePubMedGoogle Scholar
- Tanaka R, Miwa Y, Mou K, Tomikawa M, Eguchi N, Urade Y, Takahashi-Yanaga F, Morimoto S, Wake N, Sasaguri T: Knockout of the l-pgds gene aggravates obesity and atherosclerosis in mice. Biochem Biophys Res Commun. 2009, 378: 851-856. 10.1016/j.bbrc.2008.11.152.View ArticlePubMedGoogle Scholar
- Dyson M, Alloosh M, Vuchetich JP, Mokelke EA, Sturek M: Components of metabolic syndrome and coronary artery disease in female Ossabaw swine fed excess atherogenic diet. Comp Med. 2006, 56: 35-45.PubMedGoogle Scholar
- Iacobellis G, Singh N, Wharton S, Sharma AM: Substantial changes in epicardial fat thickness after weight loss in severely obese subjects. Obesity (Silver Spring). 2008, 16: 1693-1697. 10.1038/oby.2008.251.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.